Search research articles
Contact Us
Filters
Showing results (11-20 of 93) with videos related to
Page
of 10
Sort By:
Gynecologic Oncology
|
February 10, 2004
Concurrent ovarian-type primary peritoneal adenocarcinoma and peritoneal choriocarcinoma. A case report and review of the literature
G Pentheroudakis, J White, J Davis, et al.
Pathology Oncology Research : POR
|
March 21, 2008
Systemic dissemination in cancer of unknown primary is independent of mutational inactivation of the KiSS-1 metastasis-suppressor gene
L Dova, V Golfinopoulos, G Pentheroudakis, et al.
Medical Oncology (Northwood, London, England)
|
May 25, 2006
Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: accumulating evidence for synergy, efficacy, and safety
G Pentheroudakis, E Razis, A Athanassiadis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 30, 2001
Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours. Report of two cases
G Pentheroudakis, V J O'Neill, P Vasey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors
E Briasoulis, G Pentheroudakis, V Karavasilis, et al.
Anti-Cancer Drugs
|
October 21, 2004
Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I study
E Briasoulis, G Pentheroudakis, H Timotheadou, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 28, 2002
Non-infusional 5-fluorouracil, doxorubicin and cisplatin in the treatment of locally advanced or metastatic gastro-oesophageal adenocarcinoma
G Pentheroudakis, K C Lim, D J Dunlop, et al.
Chemotherapy
|
May 12, 2005
Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes
G Pentheroudakis, E Briasoulis, V Karavassilis, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 11, 2004
Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical features
G Pentheroudakis, L Kostadima, G Fountzilas, et al.
Experimental Oncology
|
September 30, 2021
Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis
M S Vlachou, D Mauri, G Zarkavelis, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 93) with videos related to
Sort By:
Page
of 10
Gynecologic Oncology
|
February 10, 2004
Concurrent ovarian-type primary peritoneal adenocarcinoma and peritoneal choriocarcinoma. A case report and review of the literature
G Pentheroudakis, J White, J Davis, et al.
Pathology Oncology Research : POR
|
March 21, 2008
Systemic dissemination in cancer of unknown primary is independent of mutational inactivation of the KiSS-1 metastasis-suppressor gene
L Dova, V Golfinopoulos, G Pentheroudakis, et al.
Medical Oncology (Northwood, London, England)
|
May 25, 2006
Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: accumulating evidence for synergy, efficacy, and safety
G Pentheroudakis, E Razis, A Athanassiadis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 30, 2001
Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours. Report of two cases
G Pentheroudakis, V J O'Neill, P Vasey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors
E Briasoulis, G Pentheroudakis, V Karavasilis, et al.
Anti-Cancer Drugs
|
October 21, 2004
Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I study
E Briasoulis, G Pentheroudakis, H Timotheadou, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 28, 2002
Non-infusional 5-fluorouracil, doxorubicin and cisplatin in the treatment of locally advanced or metastatic gastro-oesophageal adenocarcinoma
G Pentheroudakis, K C Lim, D J Dunlop, et al.
Chemotherapy
|
May 12, 2005
Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes
G Pentheroudakis, E Briasoulis, V Karavassilis, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 11, 2004
Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical features
G Pentheroudakis, L Kostadima, G Fountzilas, et al.
Experimental Oncology
|
September 30, 2021
Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis
M S Vlachou, D Mauri, G Zarkavelis, et al.
Page
of 10